Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in children in the United States-Reference-Cited by-同舟云学术

Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in children in the United States

Published:2020-11-05 Issue:12 Volume:23 Page:1653-1660
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Hu Tianyan¹,Weiss Thomas¹,Owusu-Edusei Kwame¹,Petigara Tanaz¹^ORCID

Affiliation:

1. Center for Observational and Real-world Evidence, Merck & Co., Inc., Kenilworth, NJ, USA

Funder

Merck Sharp & Dohme Corp.

Merck & Co., Inc.

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1840216

Reference47 articles.

1. Centers for Disease Control and Prevention [Internet]. The Pink Book: epidemiology and prevention of vaccine-preventable diseases. Chapter 17: pneumococcal disease. Atlanta (GA): CDC; 2018 [2019 September 18]. Available from: https://www.cdc.gov/vaccines/pubs/pinkbook/pneumo.html

2. Centers for Disease Control and Prevention [Internet]. Active bacterial core surveillance (ABCs) report: Streptococcus pneumoniae. Atlanta (GA): CDC; 2017 [2020 April 15]. Available from: https://www.cdc.gov/abcs/reports-findings/survreports/spneu17.html

3. Pneumococcal Meningitis in Children: Epidemiology, Serotypes, and Outcomes From 1997–2010 in Utah

4. Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques

5. Healthcare utilization and cost of pneumococcal disease in the United States

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Burden of invasive pneumococcal disease, non-invasive all-cause pneumonia, and acute otitis media in hospitalized US children: a retrospective multi-center study from 2015-2020;2024-04-09

2. Trends inStreptococcus pneumoniaeAntimicrobial Resistance in US Children: A Multicenter Evaluation;Open Forum Infectious Diseases;2023-03-01

3. Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028);Human Vaccines & Immunotherapeutics;2023-01-02

4. A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION);Vaccine;2023-01

5. Letter to the Editor Regarding “Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age”;Infectious Diseases and Therapy;2022-11-14